FDA Flexibility Leads to First Approved Gene Therapy for Rare Blood & Immune System Disorder

Waskyra is the first FDA-approved gene therapy for the rare disease Wiskott-Aldrich syndrome and the first such approved product from a non-profit applicant, Fondazione Telethon. Data from Waskyra’s pivotal studies were presented this week during the annual meeting of the American Society of Hematology. The post FDA Flexibility Leads to First Approved Gene Therapy for…

Read More

How Improved Interoperability Drives Greater Health Equity

Interoperability offers the potential to improve the quality of care by providing more comprehensive, accurate health information to doctors and other providers, to patients and their caregivers, as well as to healthcare payers, and others with a valid need. The post How Improved Interoperability Drives Greater Health Equity appeared first on MedCity News.

Read More

In Axing mRNA Contract, Trump Delivers Another Blow to US Biosecurity, Former Officials Say

The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses is the latest blow to national defense, former health security officials said. They warned that the U.S. could be at the mercy of other countries in the next pandemic. “The administration’s actions are gutting our deterrence from…

Read More